Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC
https://investors.diffusionpharma.com/News/news-details/2022/Diffusion-Pharmaceuticals-Announces-Strategic-Review-Process-to-Evaluate-Value-Enhancing-Alternatives-including-Opportunities-to-Better-Leverage-TSC/default.aspx